Roivant Sciences Analyst Program
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. They do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.
They have built 15 Vants to date and have raised over $3 billion to pursue their mission. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, sickle cell disease, and multiple rare and fatal pediatric conditions.
In addition to their biopharmaceutical subsidiaries, they also build technology-focused Vants focused on improving the process of developing and commercializing medicines.
They are currently recruiting for a two year tech-focused analyst program (apply here), specifically targeting seniors with programming skills